News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
151,013 Results
Type
Article (3110)
Company Profile (93)
Press Release (147810)
Section
Business (47492)
Career Advice (89)
Deals (8428)
Drug Delivery (3)
Drug Development (29328)
Employer Resources (12)
FDA (2378)
Job Trends (3209)
News (86399)
Policy (5621)
Tag
2024 BioCapital Digital (3)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (2)
2024 Biotech Bay Standard (4)
2024 Biotech Beach Digital (2)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (1)
2024 Genetown Standard (3)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (3)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
Academia (145)
Allergies (24)
Alliances (10675)
ALS (24)
Alzheimer's disease (282)
Antibody-drug conjugate (ADC) (25)
Approvals (2409)
Artificial intelligence (30)
Autoimmune disease (5)
Bankruptcy (50)
Best Places to Work (2844)
BIOSECURE Act (1)
Biosimilars (19)
Biotechnology (63)
Bladder cancer (15)
Brain cancer (11)
Breast cancer (46)
Cancer (485)
Cardiovascular disease (29)
Career advice (81)
Career pathing (2)
CAR-T (38)
Cell therapy (89)
Cervical cancer (2)
Clinical research (25137)
Collaboration (179)
Compensation (222)
Complete response letters (2)
COVID-19 (355)
CRISPR (5)
C-suite (67)
Cystic fibrosis (20)
Data (592)
Depression (10)
Diabetes (49)
Diagnostics (312)
Diversity, equity & inclusion (2)
Drug discovery (20)
Drug pricing (2)
Drug shortages (1)
Duchenne muscular dystrophy (9)
Earnings (21091)
Editorial (2)
Employer branding (1)
Employer resources (11)
Events (30970)
Executive appointments (211)
FDA (2635)
Featured Employer (18)
Friedreich's ataxia (1)
Frontotemporal dementia (1)
Funding (131)
Gene editing (9)
Generative AI (1)
Gene therapy (27)
GLP-1 (126)
Government (375)
Guidances (12)
Healthcare (1708)
Huntington's disease (5)
IgA nephropathy (6)
Immunology and inflammation (18)
Indications (10)
Infectious disease (374)
Inflammatory bowel disease (38)
Influenza (7)
Intellectual property (21)
Interviews (12)
IPO (5221)
IRA (2)
Job creations (508)
Job search strategy (75)
Kidney cancer (5)
Layoffs (32)
Legal (698)
Liver cancer (14)
Lung cancer (83)
Lymphoma (37)
Management (4)
Manufacturing (62)
MASH (27)
Medical device (289)
Medtech (289)
Mergers & acquisitions (3382)
Metabolic disorders (141)
Multiple sclerosis (22)
NASH (7)
Neurodegenerative disease (16)
Neuropsychiatric disorders (2)
Neuroscience (405)
NextGen: Class of 2025 (697)
Non-profit (181)
Northern California (873)
Now hiring (2)
Obesity (63)
Opinion (14)
Ovarian cancer (21)
Pain (16)
Pancreatic cancer (13)
Parkinson's disease (30)
Patents (43)
Patient recruitment (32)
Peanut (14)
People (14884)
Pharmaceutical (32)
Phase I (7389)
Phase II (11455)
Phase III (8257)
Pipeline (304)
Policy (5)
Postmarket research (478)
Preclinical (2681)
Press Release (11)
Prostate cancer (16)
Psychedelics (4)
Radiopharmaceuticals (90)
Rare diseases (71)
Real estate (931)
Recruiting (7)
Regulatory (4934)
Reports (8)
Research institute (182)
Resumes & cover letters (6)
RSV (3)
Schizophrenia (31)
Series A (20)
Series B (15)
Service/supplier (1)
Sickle cell disease (5)
Southern California (680)
Sponsored (1)
Startups (714)
State (1)
Supply chain (7)
United States (6387)
Vaccines (82)
Venture capitalists (1)
Webinars (3)
Weight loss (13)
Women's health (1)
Date
Today (50)
Last 7 days (186)
Last 30 days (938)
Last 365 days (10374)
2025 (1914)
2024 (10739)
2023 (12368)
2022 (14237)
2021 (16004)
2020 (13727)
2019 (8837)
2018 (6248)
2017 (8072)
2016 (6574)
2015 (8393)
2014 (6322)
2013 (4517)
2012 (4446)
2011 (4448)
2010 (4453)
Location
Africa (79)
Alabama (14)
Arizona (17)
Arkansas (2)
Asia (11574)
Australia (1282)
California (1799)
Canada (422)
China (228)
Colorado (55)
Connecticut (74)
Delaware (64)
Europe (21295)
Florida (223)
Georgia (58)
Idaho (3)
Illinois (76)
India (4)
Indiana (53)
Japan (29)
Kansas (48)
Kentucky (7)
Maine (2)
Maryland (183)
Massachusetts (1418)
Michigan (31)
Minnesota (64)
Missouri (9)
Nebraska (5)
Nevada (3)
New Hampshire (2)
New Jersey (662)
New Mexico (4)
New York (639)
North Carolina (289)
Northern California (873)
Ohio (49)
Oklahoma (2)
Oregon (9)
Pennsylvania (318)
Puerto Rico (1)
South America (122)
Southern California (680)
Tennessee (7)
Texas (172)
Utah (32)
Virginia (36)
Washington D.C. (8)
Washington State (97)
Wisconsin (7)
151,013 Results for "oxeia biopharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
OXEIA BIOPHARMACEUTICALS ANNOUNCES NEW BOARD AND MANAGEMENT TEAM MEMBERS AND RELOCATES CORPORATE HEADQUARTERS TO BOSTON
Oxeia Biopharmaceuticals today announced two new board members and additions to its executive leadership team.
January 20, 2022
·
5 min read
Drug Development
OXEIA ANNOUNCES POSITIVE INTERIM RESULTS OF PHASE 2 TRIAL FOR OXE103 FOR THE TREATMENT OF CONCUSSIONS
Oxeia Biopharmaceuticals Inc., a clinical stage biotech company developing a drug treatment for concussion to address underlying neuro-metabolic dysfunction and axonal injury, announced today the completion of an interim analysis of its ongoing Phase 2 clinical trial of OXE103 at the University of Kansas Medical Center.
August 3, 2022
·
3 min read
Press Releases
Biopharmaceuticals Market Size Expected to Reach USD 1,796.21 Bn by 2034
February 17, 2025
·
1 min read
Press Releases
PharmaCord and Mercalis to Merge, Creating Next-Generation Platform to Meet Evolving Needs of the Biopharmaceutical Industry
March 12, 2025
·
7 min read
Press Releases
U.S. Biopharmaceuticals Market Size to Surpass USD 635.37 Billion by 2034
February 19, 2025
·
1 min read
Press Releases
Biopharmaceutical Third Party Logistics Market Size to Surge USD 271.76 Billion by 2034
February 26, 2025
·
1 min read
Press Releases
Seasoned Biopharmaceutical Industry Executives Teri Lawver and Jerry Durso Appointed to Altimmune Board of Directors
February 26, 2025
·
4 min read
Press Releases
U.S. Biopharmaceuticals Contract Manufacturing Market Size to Hit USD 7.83 Billion by 2033
February 26, 2025
·
1 min read
Press Releases
Immedica to Acquire Biopharmaceutical Company Marinus Pharmaceuticals, Inc.
December 30, 2024
·
11 min read
Press Releases
Biopharmaceutical CMO and CRO Market Size to Worth USD 72.39 Bn by 2034
February 6, 2025
·
1 min read
1 of 15,102
Next
